IFP Advisors’s Lantern Pharma LTRN Stock Holding History

IFP Advisors’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$558	Buy	+552	New	+$1.33K	﹤0.01%	4651

Other funds holding LTRN

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Entrust Financial Wayne, Pennsylvania $205M AUM 12.8% 1-Year Est. Return

Key Financial Inc West Chester, Pennsylvania $614M AUM 14.43% 1-Year Est. Return

IFP Advisors's LTRN Position: Q3 2026 in Review

IFP Advisors opened a new position in Lantern Pharma (LTRN) in Q3 2026: 552 shares worth $558. The stake represents ﹤0.01% of the portfolio and ranks #4651 among its holdings.

8 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

IFP Advisors held 552 shares of Lantern Pharma worth $558 as of Q3 2026.
Lantern Pharma was a new IFP Advisors position in Q3 2026.
Lantern Pharma made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4651 holding.
8 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.